Understanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreNew Tests and Therapies Enable Personalized Cancer Treatment
Oncology is one of the most complex areas of medical care. Evernorth’s cancer consult service pairs subspecialists from leading cancer centers with community oncologists, improving access to the best ...
Read MoreInnovation in hemophilia drug development and cost-efficiency tools
As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.
Read MoreThree specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read MoreSimplifying medical benefit drug management complexities
An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.
Read MoreThe importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read MorePharmacy in Focus
See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.
Read MoreUnderstanding hereditary angioedema (HAE)
Breaking down what plan sponsors should know about HAE, its challenges and therapies.
Read MoreThe benefits of timely and actionable specialty reporting
A comprehensive suite of reporting tools—and the right specialty partner to interpret data—can be invaluable for plan sponsors.
Read More